Synaptic Potentiation in Hippocampus by eEF2K Inhibitor A484954
Hippocampus · 2026-05 · 36 (3)
DOI: 10.1002/hipo.70091 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hippocampus, online erschienen am 27.03.2026. Verfasst von Qian Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Elongation Factor 2 Kinase, Long-Term Potentiation, Hippocampus. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, National Institute on Aging.
Abstract (Originalsprache)
An important mechanism controlling protein synthesis is through phosphorylation of the eukaryotic elongation factor 2 (eEF2) by its kinase eEF2K. Hyperphosphorylation of eEF2 is linked to many neuronal diseases characterized by cognitive impairments. Consistently, recent studies show that the inhibition of the eEF2K signaling via genetic or pharmacological approaches can alleviate synaptic failure and dementia syndromes in mouse models of Alzheimer's disease (AD) and related dementias (ADRDs). One commonly used tool to study eEF2K signaling is A‐484954 (or AG), a small molecule compound that is considered a highly selective and potent eEF2K antagonist. Here we reported that the AG compound (at three doses) can induce chemical long‐term potentiation (LTP) in acute hippocampal slices from mice. Taking advantage of two transgenic mouse models with eEF2K knockout or overexpression, we further demonstrated that eEF2K‐independent mechanisms contribute to chemical LTP induced by AG (dose‐dependent). Our data suggest cautious interpretation of findings on neuronal effects of eEF2K inhibitors such as AG. Future investigations are warranted to elucidate the detailed molecular mechanisms underlying the effects of AG compound and other eEF2K inhibitors on synaptic and cognitive function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Gerontology and Geriatric Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
- Department of Pharmacology, Rutgers Robert Wood Johnson Medical School, Piscataway, New Jersey, USA.
- Department of Translational Neuroscience, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
Förderung
- NIA NIH HHS
- National Institute on Aging
Zitieren
APA
Yang, Q., Li, T., Jester, H. M., Su, Q., Zhou, X., Ryazanov, A. G., & Ma, T. (2026). Synaptic Potentiation in Hippocampus by eEF2K Inhibitor A484954. Hippocampus, 36(3). https://doi.org/10.1002/hipo.70091
Vancouver
Yang Q, Li T, Jester HM, Su Q, Zhou X, Ryazanov AG, et al. Synaptic Potentiation in Hippocampus by eEF2K Inhibitor A484954. Hippocampus. 2026;36(3). doi:10.1002/hipo.70091
BibTeX
@article{Yang2026,
author = {Yang, Qian and Li, Tian and Jester, Hannah M and Su, Qiang and Zhou, Xueyan and Ryazanov, Alexey G and Ma, Tao},
title = {Synaptic Potentiation in Hippocampus by eEF2K Inhibitor A484954},
journal = {Hippocampus},
year = {2026},
volume = {36},
number = {3},
doi = {10.1002/hipo.70091}
}
EUVIMED